SCHEMBL7447268

SCHEMBL7447268

COC(=O)C(CC=O)C(CC(=O)O)c1cccc(F)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.40
KMT2A Q03164 2/20 0.39
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
MAPK1 P28482 1/20 0.39
FFAR1 O14842 2/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
ALOX15 P16050 1/20 0.39
CYP2C19 P33261 1/20 0.39
CYP26A1 O43174 1/20 0.39
CNR2 P34972 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC5 Q9UQL6 1/20 0.38
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
GAA P10253 1/20 0.37
CTSA P10619 1/20 0.36
MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7446642 0.89 KDM4E (0.39) KDM4EKMT2APOLBMAPTMAPK1
SCHEMBL20826236 0.81 HDAC4 (0.44) KDM4EKMT2APOLBMAPTMAPK1
SCHEMBL490284 0.74 KMT2A (0.51) KMT2APOLBHDAC4HDAC7HDAC5
SCHEMBL27338142 0.74 FFAR1 (0.45) KMT2APOLBMAPTMAPK1FFAR1
SCHEMBL18048626 0.72 MAPT (0.45) KMT2APOLBMAPTCYP2D6CYP2C19
SCHEMBL25242939 0.71 HDAC4 (0.47) KDM4EKMT2APOLBMAPTMAPK1
SCHEMBL31038318 0.71 HDAC4 (0.47) KDM4EKMT2APOLBMAPTMAPK1
SCHEMBL31726687 0.71 HDAC4 (0.47) KDM4EKMT2ACYP2C9CYP2C19CNR2
SCHEMBL29449418 0.70 HDAC4 (0.50) KDM4EKMT2APOLBMAPTMAPK1
SCHEMBL75778 0.70 HDAC4 (0.50) KDM4EKMT2APOLBMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1105389-A4 INTEGRIN RECEPTOR ANTAGONISTS MERCK & CO INC (US) 2001-10-17 EP disclosed
EP-1105389-A1 INTEGRIN RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 2001-06-13 EP disclosed
US-6090944-A Alkanoic acid derivatives as αv integrin receptor antagonists MERCK & CO., INC. (US) 2000-07-18 US disclosed
WO-2000009503-A1 INTEGRIN RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 2000-02-24 WO disclosed